Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclops Dry Powder Hydroxychloroquine Pilot
NCT04497519Phase 1Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ISPM19 in coronavirus disease 2019 (COVID-19), sponsored by University Medical Center Groningen. Primary endpoint: Local tolerability defined by lung function deterioration, cough, or adverse events at 5 hours. Started Sep 2020; status: completed.
02
Drugs
ISPM19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04497519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497519.